CXCR4 and familial pancreatic carcinoma: In this interdisciplinary investigation, we combined in silico modeling of CXCR4 structure with high-throughput screening and in vitro assays in pancreatic cancer cell lines to identify novel antagonists to CXCR4-mediated cell proliferation in pancreatic cancer cells.